🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 09075V102
- Market Cap
- Large Cap
- IPO
- 10/10/2019 · $15.00/share
- ADR Ratio
- 1:1
Business: BioNTech SE was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. Its cutting-edge pipeline includes individualized mRNA-based product candidates, innovative chimeric antigen receptor T cells, novel checkpoint immunomodulators, targeted cancer antibodies and small molecules.
Company Contact
- CEO
- Ugur Sahin
- CFO
- Sierk Poetting
- Headquarters
- 228 E 45th Street, Suite 9e New York, NY 10017
- Phone
- 347-694-5321
- Investor Relations
- Victoria Meissner, Westwicke Partners · 617-528-8293 · Investors@biontech.de